Ambys Medicines Appoints Ronald Park as Chief Executive Officer

Ambys Medicines appointed Ronald Park, M.D., as Chief Executive Officer. Prior, he was EVP and General Manager for Health and DNA at Ancestry and held multiple roles at Roche and Genentech over a 17-year career, including Co-Global Head and VP for Roche’s Personalized Healthcare (PHC) Center of Excellence, General Manager for Denmark and Iceland, and Global Lifecycle Leader for Actemra.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. It is privately held and based in San Francisco.